RFK Jr. Moves to Lift Warning Labels on Testosterone Therapy (1)

June 18, 2026, 9:00 PM UTC

The US Department of Health and Human Services wants to remove some of the stigma from testosterone treatment.

The agency, through the US Food and Drug Administration, is asking manufacturers to take off warnings that have long appeared on hormone replacement therapy labels for older men whose testosterone levels decline naturally with age, it said in a statement Thursday.

The FDA a decade ago required drugmakers to study the impact of testosterone use on men at high risk of heart problems. They also had to note that the safety and efficacy of the products had not been established due ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.